NeuroVive Pharmaceutical AB ROIC
What is the ROIC of NeuroVive Pharmaceutical AB?
The ROIC of NeuroVive Pharmaceutical AB is -152.24%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on OTC compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with roic similar to NeuroVive Pharmaceutical AB
- Predictmedix has ROIC of -154.59%
- Helius Medical Technologies has ROIC of -154.03%
- Titan Medical has ROIC of -153.87%
- Cardinal Resources has ROIC of -153.72%
- Ecc Ventures 3 Corp has ROIC of -153.21%
- Thin Film Electronics ASA has ROIC of -152.63%
- NeuroVive Pharmaceutical AB has ROIC of -152.24%
- URA Plc has ROIC of -152.11%
- Josemaria Resources has ROIC of -151.90%
- Canadian Cannabis has ROIC of -151.48%
- Ximen Mining has ROIC of -150.81%
- Euro Sun Mining has ROIC of -150.66%
- Eskay Mining has ROIC of -150.63%